Key messagesThe authors of this Cochrane systematic review, published today by Cochrane’s Infectious Diseases Group, found no evidence to support the use of ivermectin for treating or preventing COVID-19 infection, but the evidence base is limited.

The Cochrane Methods team has defined a programme of work to improve the quality and impact of Cochrane reviews in public health with the support of the 

The INGUIDE Program is a comprehensive, evidence-based, and up-to-date training program for guideline recomme

In 2020, Cochrane’s editorial response to COVID-19 pandemic brought together collaborations across our global organization to publish reviews addressing stakeholder needs as they emerged.

An obstetrics pioneer and prominent influencer in the early days of the formation of Cochrane, Dr. Murray Enkin was instrumental in developing evidence-based perinatal clinical trials and systematic reviews, challenging many common interventions not supported by research evidence.

Dr. Cathy Yuan was a Gastroenterologist and a lecturer in Sun Yet-sen University of Medical Science in Guangzhou, P.R. China, with an MD, an MSc and a PhD degree. In 2001, Cathy immigrated to Canada, where she pursued her second Master’s degree in Clinical Epidemiology at McMaster University.

Cochrane Library releases updated Special Collection on diagnosing tuberculosis

Cochrane has signed a World Health Organization (WHO) Declaration that calls for a more equitable rollout of COVID-19 vaccines.While several countries currently have vaccination programmes up and running, the global distribution of vaccines has so far been unequal. Many low- and middle-income countries are yet to receive any doses and face uncertainties about access.